TRA Stock Overview
Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for TRA from our risk checks.
Traphaco Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫81,000.00 |
| 52 Week High | ₫95,900.00 |
| 52 Week Low | ₫75,000.00 |
| Beta | 0.35 |
| 1 Month Change | -2.41% |
| 3 Month Change | 2.53% |
| 1 Year Change | -10.00% |
| 3 Year Change | 16.55% |
| 5 Year Change | 20.00% |
| Change since IPO | 665.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| TRA | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | -3.8% | -0.7% | 0.9% |
| 1Y | -10.0% | 16.3% | 14.9% |
Return vs Industry: TRA underperformed the VN Pharmaceuticals industry which returned 15.7% over the past year.
Return vs Market: TRA underperformed the VN Market which returned 14.9% over the past year.
Price Volatility
| TRA volatility | |
|---|---|
| TRA Average Weekly Movement | 3.9% |
| Pharmaceuticals Industry Average Movement | 3.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in VN Market | 7.0% |
| 10% least volatile stocks in VN Market | 2.4% |
Stable Share Price: TRA has not had significant price volatility in the past 3 months.
Volatility Over Time: TRA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1972 | 1,481 | Ma Tran | www.traphaco.com.vn |
Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. Its pharmaceutical products include vitamins and minerals, sedatives, herbal supplements, anti-inflammatory drugs, mouth-nose-throat drugs, drugs used in eye, topical treatment, analgesics and anti-inflammatory, brain supplements, antihistamines, parasitic drugs, antifungals, antibiotics, antiviral drugs, gynecological medicines, insecticides, cardiovascular medicines, gastrointestinal drugs, immune supplements and antioxidants, osteoarthritis drugs, and respiratory drugs, as well as disease prevention products. The company also offers supplements, cosmetics, and imported products.
Traphaco Joint Stock Company Fundamentals Summary
| TRA fundamental statistics | |
|---|---|
| Market cap | ₫3.36t |
| Earnings (TTM) | ₫229.44b |
| Revenue (TTM) | ₫2.30t |
14.6x
P/E Ratio1.5x
P/S RatioIs TRA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TRA income statement (TTM) | |
|---|---|
| Revenue | ₫2.30t |
| Cost of Revenue | ₫1.05t |
| Gross Profit | ₫1.24t |
| Other Expenses | ₫1.02t |
| Earnings | ₫229.44b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.54k |
| Gross Margin | 54.15% |
| Net Profit Margin | 9.98% |
| Debt/Equity Ratio | 11.3% |
How did TRA perform over the long term?
See historical performance and comparison